^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AIU2008

    i
    Other names: AIU2008
    Company:
    Korea Institute of Radiological and Medical Sciences
    Drug class:
    FLT3 inhibitor
    Related drugs:
    almost4years
    Anti-leukemic Activity of AIU2008 in FLT3-ITD-positive Acute Myeloid Leukemia. (PubMed, Anticancer Res)
    AIU2008 is a promising FLT3 targeting agent, and may be used in combination with PARP inhibitors for the treatment of AML.
    Journal • PARP Biomarker
    |
    FLT3 (Fms-related tyrosine kinase 3)
    |
    AIU2008